lntegrins represent a candidate group of cell surface receptors that may control the homing and population of the thymus by T-cell precursors and the subsequent migration of developing thymocytes through the thymic architecture. We have used multiparameter flow cytometric methods to characterize the expression of several members of the integrin family (a3pl. a4pl. a5pl. a6p1, and aLp2) on thymocyte subpopulations and have correlated integrin expression with other well-defined thymocyte differentiation markers. a4p1 was expressed by all thymocytes, but expression was highest on CD4-CD8-double-negative (DN) cells, high on CD'CD8+ double-positive (DP) cells, and lowest on mature T HE ADVENT OF multiparameter flow cytometry has facilitated the dissection of the maturational process of T lymphocytes in the thymus. A variety of phenotypic markers has been described whose differential expression permits the identification of discrete stages during murine or human thymocyte development.'" Thus, in humans, the most immature T-cell precursors enter the thymus as CD4-CD8-CD3-(triple-negative [TN]) cells,',4 initially express CD4,4-6 then CD8, and as they begin to rearrange their T-cell receptor (TCR) genes and upregulate CD3Y become CD4'CD8+CD3'"'"' (double-positive [DP]) thymocytes. After positive and negative selection, the surviving cells continue to increase their levels of CD3 expression, and downregulate either CD8 or CD4 to become CD4+CDS-CD3*' or This is a US govenunent work. There are no restrictions on its use. 0006-4971/95/8611-0036$0.00/0 4206 single-positive (SP) cells. a3p1, a5pl. and a6p1 were present on 13%, 63%. and 26% of thymocytes, respectively, with maximal levels of expression on DN and SP cells, and low levels of expression on DP cells. Simultaneous analysis of a4p1, a5p1, and CD3 expression suggested a pathway of Tcell differentiation in the thymus in which the majority of the DN cells were a4plh'a5plh', the DP cells a4plh'a5p1'"~-, and the most mature SP cells were a4pl'oa5pl'nt. The stagespecific expression of integrins strongly implies their functional involvement during T-cell maturation in the thymus. This is a US government work. There are no restrictions on its use.
cytes, but their expression is upregulated with maturation to the SP stage. CD69 expression is upregulated at the "transitional" stage, as the DP become SP, and remains high on the SP ~e l l s .~' -~~ Recently, several groups have sought to include adhesion molecules (particularly the integrins) in this list of thymocyte stage-specific markers.2s-32 Integrins are a family of heterodimers constructed from noncovalently associated pairs of at least 8 a and 14 p chain^.^"^' Potential ligands for the integrins include several cellular molecules (vascular cell adhesion molecule [VCAMI-1, intercellular adhesion molecule [ICAM] -1, -2, -3) and extracellular matrix proteins (collagen, laminin, merosin, fibronectin @W], vitronectin)."-" In addition to their role in the regulation of the migration/ homing of mature peripheral myeloid and lymphoid integrins have been shown to play a crucial role in myelopoiesis and lymphopoiesis in the Recent studies have suggested that a number of members of the integrin family may also play a role in thymocyte differentiation. In the a minor (10% to 1.5%) subpopulation of thymocytes constitutively bound to FN or to thymic stromal cells and the binding could be inhibited by monoclonal antibodies (MoAbs) to a 4 p l or aS/?l, or antibodies to FN. The adherent subpopulation contained the majority of DN cells and some large CD4+CD8+TCR1" cells. Constitutive binding appeared to correlate with the level of a 4 p l expression as DN and CD4-CD8'"' murine thymocytes expressed high levels of (~4 0 1 , whereas levels were markedly reduced on DP cells.27 The interaction of aLp2 with ICAM-I may also be critical for thymocyte development as expression of aLp2 can be detected on day 14 of gestation and by day 16 is present on 90% of thymocytes"; furthermore, the addition of anti-ICAM-1 or anti-aLP2 antibodies to day 13 or 14 murine fetal thymic organ cultures prevented the development of DP thymocyte^.^^
We have recently shown that a major portion of human DP thymocytes adhere to FN or VCAM-1. The adherent population was enriched in DP cells with an immature phenotype (CD3'", CD69'"), while the FN nonadherent DP population was enriched for "transitional" cells (CD3h', CD69hi); the adherence was mediated by a4p1, which appeared to be constitutively active. In contrast, the capacity of thymocytes to proliferate to the combination of immobilized anti-CD3 and FN was exclusively a property of the FN nonadherent For personal use only. on September 24, 2017. by guest www.bloodjournal.org From population and was mediated by (~5 p 1 .~~ Thus, the regulation of the expression and/or function of a 4 p l and a 5 P l may play a critical role in the process of human thymocyte differe n t i a t i~n .~~ In this report, we have used multiparameter flow cytometric methods to more precisely characterize the expression of several members of the integrin family (a3p1, a4P1, d p l , a6/31, and aLP2) on different thymocyte subpopulations, to correlate integrin expression with the expression of a number of more "classical" thymocyte differentiation markers, and to develop a scheme for the role of integrins in the thymocyte maturational processes.
MATERIALS AND METHODS
Cell prepararion. Thymus fragments were obtained during elective cardiac surgery for valvular malformations on children aged 3 days to 7 years. Thymi were minced and pressed through a 60-mesh stainless steel screen. Thymocytes were then separated by Ficolldiatrizoate gradient (Organon Teknika, Durham, NC).
Antibodies. 
RESULTS
Expression of a401 on thymocyte subpopulations. As previously 98.3% -+ 1.6% of human thymocytes expressed a 4 p l with a relatively homogeneous level of expression as a single peak on fluorescence histogram (Fig 1, top panel) . Human postnatal thymocytes can be easily divided into four (DN 3.3% 2 1.0%, DP 78.7% C 4.9%, CD4SP 11.8% 5 2.9%, CD8SP 6.0% k 1.9% [n = 221) major subpopulations and further analysis of the expression of a 4 p l on these subpopulations using multiparameter staining uncovered an interesting heterogeneity (Fig 1, bottom  panels) . The a 4 p l -fraction contained predominantly DN cells, and of the total DN cells, 58% were a4p1- (Fig 1,  Rl) . However, further analysis of these a4p1-cells showed that the majority were also CD7-and CD3- (Fig 2 and data  not shown) . Thus, they are not T-lineage cells and will be excluded from further analysis. Additionally, approximately 12.5% of the DNs were y6 TCR+.
The a4p1'" population (Fig 1, R2 ; 45% to 50% of a4pl' cells) was depleted of DN cells (14.1% of total) and contained roughly half (47.0%) of the total DP cells; surprisingly, this population contained virtually all the CD8+SP cells (86.4%) and 60% of the CD4+SP thymocytes. These CD4'SP cells were almost exclusively CD4h'. In contrast, the a4plh' subset (Fig 1, R3 ) was enriched for (immature) CD4'" SP cells; CD8+SP and CD4hi SP (mature) thymocytes were virtually absent. Indeed, the brightest 5% of a 4 p l + cells (R4 in Fig 1) were 81% DP and contained 15.7% CD4'" SP cells.
Two-color immunofluorescence analysis using other known thymocyte differentiation markers was used to further characterize the a4plhi and a4pl'" subsets (Fig 2) . The a4Pl-fraction is negative for all T-lymphoid markers. The cy4Pl' O subset contained the majority of CXBTCR~ (89.1% of the &TCRhi cells were a4Pll0), CD3h' (92.7%), CDShi (74.9%), CD28h' (80.0%), CD69hi (93.3%) thymocytes (Fig  2, a, b, e-g). The a4pll" cells were also CD34-(only 1.9% of a4Pl'" thymocytes were CD34+), and CD1ai""Lo (Fig 2,  c and d ). On the other hand, the a4/31h' subset contained phenotypically less mature thymocytes, specifically a& , CD5'", CD28lo, and CD69". This subset also contained 85.6% of the CD34+ cells, and the majority of CDlahi cells. Indeed, as levels of TCR, CD3, CD5, CD28, and CD69 increased, the level of a 4 p l tended to decrease. Cells bearing the y6 TCR, CD2 and CD7 (data not shown), were equally divided between a4,81'" and a4plhi subsets. Preliminary data indicate that of the a 4 p l + fraction, 10% are y6 TCR+, which represents approximately one third of all the y6 TCR+ cells in the thymus (data not shown). Taken together, these studies demonstrate that the level of expression of a4p1 varies markedly during different stages of thymocyte development with the highest levels of expression seen on the CD4" SP cells and on the least mature DP populations.
Expression of a5PI on thymocyte subpopulations. a 5 p l was present on 63.2% 2 14.7% of thymocytes with a relatively heterogeneous level of expression as indicated by a broad peak on the histogram (Fig 3, top panel) . When the a 5 p l + population was split (at the channel of peak fluorescence) into a5@lhi and a5/3li0 subpopulations, we also observed a correlation between the levels of expression of a 5 p l and CD4/CD8 (Fig 3, bottom population (Fig 3, R2) was predominantly DP and contained few DN (6.1% of total DN), CD4+SP (6.9% of total CD4+SP), or CDX'SP (14.4% of total CD8+SP) thymocytes.
The a5/31h' subset (Fig 3, R3 ; 50% of total cells) was enriched for CD4+SP (86.4% of total) and CDX'SP (58.5% of total), and contained 39.6% of the DN cells; however, the brightest 5% of a 5 p l + thymocytes were markedly enriched for CD4"SP cells and DN cells (Fig 3, R4 ).
We next compared the level of expression of a5pl with the other markers that define thymocyte differentiation. The relative fluorescence intensity of a 5 p l staining tended to be highest in immature (aPTCR'O) and mature (apTCRh') compartments, and lowest in the intermediate (aPTCR"') subset (Fig 4a) . The a5p l hi brightest subpopulation was enriched for cells with immature phenotypes (Figs 4, a, b , df): a/?TCR'" (75.3% of the brightest a5plh' were a/?TCR'"), CD3'" (75.2%), CD28'" (77.9%), CD69" (48.3%), and CD34hi (58.0%). In fact, as cells lose CD34, there is a concomitant decrease in a5@1 (compare with CD34 on a 4 p l h ' thymocytes, in which levels remain constant [Fig 2dl) . A similar relationship was observed for CD7 as the brightest a 5 p l + cells were also CD7h' (Fig 4c) . Cells bearing the yGTCR were virtually all a5/?lh', with about one third in the a 5 p l h ' brightest 5% (not shown).
When we analyzed thymocytes for the simultaneous expression of a 4 p l and a501 (Fig 5A) , three distinct subpopulations could be identified: a4pl'" a5pl'", a4plh' a5Pli0/~, and a4plh' a5pl When the level of expression of CD3 was correlated with levels of expression of a 4 p I l d p l (Fig  5B) , the relationships between the relative levels of expression of these integrins, the CD3 complex, and the program of T-cell differentiation in the thymus were more clearly defined. The a4pl'" a5pl'" cells (Fig 5A, R1 ) contained predominantly CD3'"' (36%) and CD3h' (55%) thymocytes (Fig 5B, bottom panel) , a4plh' a5fll'"-cells (Fig 5A, R2 ) contained equivalent numbers of CD3" (45%) and CD3"'' (49%) thymocytes (Fig 5B, bottom panel) , while the a 4 p 1 h' a5plh' cells (Fig 5A, R3) were predominantly CD3-cells (84%, Fig 5B, bottom panel) . The CD3 staining profile of whole thymus is shown in Fig 5B (top panel) for comparison purposes. These data suggest a pathway of T-cell differentiation in the thymus in which the majority of the precursor cells are a4plhi a5plh' (R3), the DP population a4plh' a5pl'"'-(R2), and the most mature SP cells a4pl'" a5P1'"' (RI).
a3pl and a601 expression. Both a 3 p l and a 6 p l were expressed on low percentages of human thymocytes (12.8% ? 5.7% [ Fig 6A, top panel] and 26.0% ? 11.0% [ Fig 6B,  top panel] , respectively). Both the a 3 p l -and the a601 subsets (Fig 6, A and B , bottom panels, R1) were enriched in CD4SP cells (63.5% and 64.8% of total, respectively) and DN cells (70.4% and 71.1% of total, respectively). When the levels of expression of a 3 p l and a 6 p l were correlated a with the levels of expression of the a@ TCR, CD3, and CD34, the highest levels of expression were present on CD3'" and CD3h' thymocytes, with lower levels present on the CD3'"' subset (Fig 7, B and E) . The majority of the CD34h' cells were a6Plh', but a3Pl'" (Fig 7C and F) .
&LP2 integrin expression in human thymocyte subsets. As previously reported,-almost all human thymocytes expressed aLP2 (99.0% +-0.6%) with a relatively homogenous level of expression (Fig 8A, top panel) . aLP2- (Fig SA, R1 ) cells were virtually (92.9%) all DN, but almost half (45.9%) of the DN population was a L p 2~ (Fig 8A, R3) . DP thymocytes were slightly enriched in the ( Y L P~~" population ( Fig  8A, R2) , CD4'SP enriched in the C K L P~~' subset (Fig 8A, 
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Log Fluorescence -R3), and CD8+SP cells were equally divided between the two. Expression of aLP2 was moderate (ie, in the lower half of the ~yLp2~' subset) on CD3Cbearing cells (Fig 8B, panel  c, R2) , and the level of expression tended to increase with thymocyte maturation. Thus, @TCRh', CD3h', CDSh' (not shown), CD7h' (not shown), CD2Sh', and CD69h' thymocytes tended to be ~yLp2~' (Fig 8B, panels a, b, d, e) .
DISCUSSION
We have analyzed the expression of a number of members (a3p1, a4p1, aSPl, a601, and aLP2) of the integrin superfamily on human thymocytes and have correlated their expression with the expression of a number of other membrane antigens that have previously been used to define pathways of T-cell maturation within the thymus in humans and experimental animals. Because integrins have been shown both to control the homing and migration of cells as well as to function as costimulatory molecules for the activation of peripheral T lymphocytes and thymocytes, the regulation of their expression on various thymocyte subsets should provide important insights into their possible functional role at different stages of thymocyte maturation. The control of integrin function may exist at several different levels including selective expression of an integrin on a thymocyte subset(s) as well as quantitative differences in the level of expression of integrins that are widely expressed on all thymocytes. In addition, integrins may exist in active and inactive states in terms of their ability to bind their target ligands and we have previously shownz4 that a major subset of thymocytes expresses cy401 in a constitutively active form. By the use of multiparameter flow cytometric techniques, we have obtained clear evidence for differential expression of most of the integrins studied ( Table 1) . a4Pl is expressed on almost all thymocytes (98%), yet its pattern of thymocyte expression appears to be unique. Its level of expression was highest on DN thymocytes, decreased slightly on DP T cells, and was 10-fold lower on SP cells. The high level of expression of a401 on DN and DP cells appears to correlate with its functional activity as Leavesley et a145 have demonstrated that a40 1, but not aL/% or platelet endothelial cell adhesion molecule-l (PECA" l), was constitutively active on CD34+ progenitor BM cells and mediated adhesion to VCAh4-1 and we have previously shownz5 that a4Pl is constitutively activated on thymocytes at least by the DP stage, but is inactive at the "transitional" and SP stages. As DP T cells with "active" a4Pl expressed almost the same level of 0401 as DP T cells with "inactive" a4P1, integrin function appears to switch off before downregulation of integrin expression. On peripheral T cells, the converse appears to be true as Shimizu et a136 have shown that integrin activation occurs before upregulation of expression.
The a4 chain can alternatively pair with the 07 chain.34 Although the HP211 MoAb does not discriminate between a4Pl and a407,4' the Act-l MoAb is specific for cy4P7. Previous reports4' indicate that unstimulated human thymus is negative for a4P7, and in our hands only 3.3% 5 1 .l% (n = 3) of thymocytes stained with this antibody. Therefore, we believe that HP2/1 almost exclusively recognizes cy401 in the thymus.
Although 05Pl is also expressed by the majority of thymocytes (60% to 70%), its pattern of expression is quite distinct from that of (~4 0 1 .
Although both of these integrins were expressed at high levels on DN T cells, the level of a501 decreased on DP cells, yet was again high on SP cells. Almost all of the constitutive capacity of thymocytes to adhere to FN appeared to be mediated by a4pl because anti-05p1 MoAbs had no effect on adhesi0n.2~ In contrast, a5P1, but not a4/3l, functioned as a costimulatory molecule for FN and anti-CD3 induced T-cell proliferation of SP and DP/transitional thymocytes. Because cu5pl acquired the capacity to deliver a costimulatory signal at the putative time of positive studies are currently underway to determine whether this property of a5pl is a prerequisite to or a consequence of thymocyte selection.
The patterns of expression of 0301 and a6Pl integrins on thymocyte subsets were quite similar to a5Pl even For personal use only. on September 24, 2017. by guest www.bloodjournal.org From however, preliminary data with the a604 specific MoAb S3/ 41 shows no staining of thymocytes. We have previously
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shown" that 10% to 15% of thymocytes adhered to laminin in the absence of stimulation, whereas 39% to 41% of thymocytes bound laminin after activation with phorbol myristate acetate (PMA) or MnZ+, We have not yet determined if the cells that express constitutive laminin binding activity are composed of a unique subset of cells that express a 3 0 1 and/ or a60 1. Both laminin or merosin will function as costimulatory molecules for thymocyte proliferation in the presence of plate-bound anti-CD3, and this costimulatory function can be inhibited by either anti-a3@1 or anti-a6@1 !
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The pattern of expression of a.501, a3p1, and a601, with high levels on the least and most mature populations and intermediate levels on the DP cells, is similar to only one of the classical thymocyte differentiation markers, CD7, a member of the Ig gene superfamily whose structure is similar to murine Thy-l. CD7 is expressed at high levels on CD34+ DN thymocytes:' intermediate on DP cells, and high on SP cells (data not shown). Anti-CD7 MoAbs can costimulate proliferation of peripheral T cells in the presence of anti-CD3 or PMA''*'* or can also be directly mitogenic for T ~e l l s~~,~~ or NK cells5' after cross-linking. Interestingly, one consequence of anti-CD7-induced activation is integrin-mediated adhesion to FN, VCAM-l, or I C A " 1 without upregdation of integrin expre~sion.~~~'' Anti-CD7-mediated integrin activation appears to be mediated by a mechanism distinct from that produced by anti-CD3 or PMA stimulat i~n . '~ Because CD7 may function as an adhesion molecule,'* it is quite possible that interaction of CD7 with its physio- logic ligand may play a role in the activation of integrin function during T-cell development in the thymus.
aLP2 was expressed at low-intermediate levels on DN and DP cells and at higher levels on SP cells. This pattern of expression is one common to several of the classical thymocyte differentiation markers including CD5, CD28, and CD69. It is likely that aLP2 interactions with ICAM-1 (CD54) may play critical roles at multiple steps during the process of thymocyte differentiation, as Singer et a157-59 have shown that both the binding of thymocytes to thymic epithelium (TE) as well as TE-dependent, phytohemagglutinininduced, SP-thymocyte activation were inhibited by MoAbs to aLP2 or ICA" 1. Similarly, addition of MoAbs to aLP2 or ICAM-1 to mouse thymic organ cultures resulted in arrest of T-cell development at the DN stage, which suggests that aLp2 has a developmentally restricted role at an early stage For the most part, our results agree with earlier, less comprehensive studies of integrin expression by human thymostudies may relate to the specific MoAbs used, to staining techniques, or to our use of fresh preparations of thymocytes in contrast to cells that had been fixed after staining or stored at 4°C for 18 hours before staining. Our results on the expression of a4Pl on human thymocytes appear to be quite distinct from studies of the expression of a401 on murine thym o c y t e~~~.~~ in which the expression of n4Pl was highest on DN thymocytes, low on DP, and very low on SP. However, we have recently used two other MoAbs to reexamine the expression of a401 on murine thymocyte subpopulations and found that its pattern of expression was virtually identical to that seen on human thymocytes (Mojcik C, Shevach EM, in preparation). In addition, as in humans, the major subpopulation that expresses a4P1 in a constitutively active form was enriched for immature DP cells rather than the DN cells as previously Studies of the differentiation of human thymocytes in vivo after injection of progenitor cells (CD34+, CD3-, CD4-, CD8-) into allogeneic thymus xenografts in severe combined immunodeficient (SCID-hu) micei5 or in vitro after injection of progenitors into fetal thymic organ cultures (FTOC) have shown the sequential appearance of CD3-CD4+CD8-, CD3-CD4'CD8+, and CD3'CD4+CD8' cells, with the later appearance of mature CD3+CD4'CD8-and CD3'CD4-CD8+ populations.'7 The expression and function of several of the integrins also appears to vary Cytes.30.35.42.43 Some of the minor differences between these during this development process and allows us to propose possible functional involvement of these molecules during the different stages of thymocyte development. If one confines the analysis to a comparison of the absolute levels of expression of the various integrins, it superficially appears that the majority of the earliest precursors (DN population, Figs 1 and 3 , R1, bottom panels) do not express either a4P 1 or (~501; however, the majority of these DN cells are neither T cells nor precursors of the T-cell lineage. On the other hand, greater than 95% of the CD34h' population expressed high levels of a4Pl and a5Pl (Figs 2 and 4 , and data not shown) and almost all of these cells were CD3-CD4-CD8-. Thus, one can conclude that the earliest T-cell precursors in the thymus probably expressed these integrins upon entry to the thymus and that these integrins may even play a role in the homing of these cells from the BM to the thymus. The expression of high levels of a4Pl (Fig 1, bottom, R3 ) or a501 (Fig 3, bottom, R4) is maintained on the CD3-CD4I0CD8-population, but while the level of a4Pl is maintained, the level of a5Pl is markedly downregulated on the DP population (Fig 3, bottom, Rl) . In contrast, the expression of a4Pl is downregulated whereas the expression of d B 1 is upregulated upon maturation of the DP cells to CD3'CD4'CD8-or CD3+CD4-CD8+ cells. Thus, a4Pl interactions with FN or VCAM-1 may modulate the transition from CD34+CD3-CD4-CD8-cells to CD3-CD4TD8-cells as well as the transition of the CD3-CD4+CD8-cells to CD3'CD4+CD8+ cells. It is quite possible that a5Pl may also be involved in some of the early steps of this process or that the downregulation of a 5 p l expression is required for maturation to DP stage. Similarly, as the constitutive activity of a4Pl is downregulated, while the expression of a5Pl is upregulated, at some point in the transition from DP to SP, integrin interactions staining of aw2 stained, gated populations. Percentages of cells wara determined as described in the legend to Fig 1. (B 
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with their target ligands may also play a role at later stages of thymocyte maturation. The ability to monitor the development of murine3' or human16 thymocytes from precursor cells in vitro in organ cultures should facilitate the evaluation of the function of these integrins at each development step by blocking their interaction with their ligands by the addition of inhibitory MoAbs or peptides. We are currently undertaking R O C and SCID-hu studies to address these issues.
